Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Yu Qin Wu
Age : 51
Country of residence : Unknown
Linked companies : Chongqing Zhifei Biological Products Co., Ltd.

Biography of Yu Qin Wu 
Presently, Yu Qin Wu is Chairman-Supervisory Board at Chongqing Zhifei Biological Products Co., Ltd.


Current positions of Yu Qin Wu 
Yu Qin Wu : Personal Network 
Most Read News 
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/13RICHARD BRANSON : Virgin Galactic acknowledges Branson's pre-launch bike ride never happened
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/13ELON MUSK : Musk defends timing of Tesla's $2.6 billion deal for SolarCity
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/13BRUNELLO CUCINELLI : Italian luxury group Cucinelli raises 2021 sales forecast again
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
More news


© 2021 People and Ownership :   
Yu Qin Wu : Connections 


Latest news about Yu Qin Wu 
07/27MediaTek Inc. Approves the Appointment of Remuneration Committee Members
CI
07/05MediaTek Inc. Announces Resignation of Remuneration Committee Members
CI
02/01Certain A Shares of Jiayou International Logistics Co., Ltd. are subject to a Lock-Up Agreement Ending on 1-FEB-2021.
CI
2020Genesis Medtech Investment (HK) Limited entered into an equity transfer agreement to acquire 80% stake in Jiangsu Ni Ke Medical Device Co., Ltd. from Livzon Pharmaceutical Group Inc., Zijin Zhonghao Investment Co., Ltd., Yongyi Yu, Wu Guangmin and other shareholders for approximately CNY 520 million.
CI
2020Taiwan Mask Corporation Announces Management Changes
CI
2020Far Eastern New Century Corporation Announces Retirement of Ru-Yu Wu as Chief Research & Development (R&D) Officer
CI
2019LiJiang YuLong Tourism Co., Ltd. Announces Executive Appointments
CI
More news